Back to discover
Disease

Neoplasms, Glandular and Epithelial

Active therapeutic pipelineEmerging researchRising momentum
4
Publications
3
Clinical trials
3
Related conditions
3
Related treatments
1
Associated genes
2023
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 1 clinical trial with recent milestones.
Major developments
Clinical Milestones1View

Research-associated treatments

Drugs and agents co-studied with this disease across the research literature — associative, not necessarily established treatments. Number shows shared papers.

Clinical trials

3 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Research activity

4 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20112023
Most influential

A phase 3 trial of bevacizumab in ovarian cancer.

The New England journal of medicine · 2011 · 1,607 cites

Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer.

The New England journal of medicine · 2019 · 220 cites
Recent publications

Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer.

The New England journal of medicine · 2019 · 220 cites

A phase 3 trial of bevacizumab in ovarian cancer.

The New England journal of medicine · 2011 · 1,607 cites
Major themes6
  • Neoplasms, Glandular and Epithelial2
  • Thymoma2
  • Thymus Neoplasms2
  • Cytoreduction Surgical Procedures1
  • Lung Neoplasms1
  • Neuroendocrine Tumors1
Leading journals3
  • The New England journal of medicine2
  • ESMO open1
  • Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer1
Leading researchers8
  • Ahmad U1
  • Alvarez Secord A1
  • Appel S1
  • Armstrong DK1
  • Asamura H1
  • Basen-Engquist K1
  • Beale P1
  • Bille A1
Affiliations (unnormalised)6
  • and Thoracic Institute at Cleveland Clinic1
  • Ankara University Faculty of Medicine1
  • Asan Medical Center1
  • Azienda Ospedaliero-Universitaria Pisana1
  • Baggiovara Civil Hospital1
  • Chaim Sheba Medical Center1

Associated genes

1 match

Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.

Related conditions

3 matches

Diseases frequently studied alongside this one. Number shows shared papers.

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Neoplasms composed of glandular tissue, an aggregation of epithelial cells that elaborate secretions, and of any type of epithelium itself. The concept does not refer to neoplasms located in the various glands or in epithelial tissue.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.